Bedfont ® Scientific Limited, a world leader in breath analysis, is calling for a wider adoption of Fractional exhaled Nitric Oxide (FeNO) testing to improve asthma management and reduce ...

Whilst this year’s theme, Healthy Beginnings, Hopeful Futures, focuses on pregnancy and early life, Bedfont ® is highlighting how FeNO testing revolutionizes asthma care, ensuring children grow ...